21Shares XRP ETF
TOXR
2 hedge funds and large institutions have $35.9M invested in 21Shares XRP ETF in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$37.1M |
| 2 |
SA
Strategic Advocates
Logan,
Utah
|
+$13.8K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| $35.9M | +$37.1M | +2,009,806 | New |
|
|
SA
2
Strategic Advocates
Logan,
Utah
| $13.7K | +$13.8K | +750 | New |
|
TOXR Hedge Fund Activity: Q4 2025 in Review
2 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in 21Shares XRP ETF (TOXR) for Q4 2025, worth a combined $35.9M.
Buyers outnumbered sellers: 2 funds opened new TOXR positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $37.1M.
- 2 institutional investors held 21Shares XRP ETF (TOXR) as of Q4 2025, up from 0 in Q3 2025.
- Funds reported $35.9M of 21Shares XRP ETF stock for Q4 2025.
- 2 funds opened new 21Shares XRP ETF positions in Q4 2025 and 0 closed out, a net change of +2 holders.
- The largest 21Shares XRP ETF buyer in Q4 2025 was Goldman Sachs, an estimated $37.1M added.
Based on aggregated 13F filings for Q4 2025.